S4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care
In season 4, episode 20 of Targeted Talks, Aaron Lisberg, MD, a thoracic medical oncologist at the University of California, Los Angeles, delves into findings from the phase 3 TROPION-Lung01 study of datopotamab deruxtecan for the treatment of patients with advanced or metastatic non–small cell lung cancer.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.